Cartesian Therapeutics
RNAC
RNAC
61 hedge funds and large institutions have $85.6M invested in Cartesian Therapeutics in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-8
Holders Change %
-11.59%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
25
Reduced
10
Closed
27
Calls
$114K
Puts
–
Net Calls
+$114K
Net Calls Change
+$97K
Top Buyers
| 1 |
MB
1
MPM BioImpact
Boston,
Massachusetts
|
$7.01M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$8.27M |
| 3 |
IC
3
Ikarian Capital
Dallas,
Texas
|
$6.55M |
| 4 |
4
BlackRock
New York
|
$11M |
| 5 |
LGM
5
Logos Global Management
San Francisco,
California
|
$2.43M |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
2
Millennium Management
New York
|
$0 |
| 3 |
CM
3
CM Management
Gulf Breeze,
Florida
|
$0 |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$0 |
| 5 |
5
Jane Street
New York
|
$0 |
